Yeager has served in executive management for over 25 years in biopharmaceutical and medical device companies with responsibility for international regulatory affairs and operation activities. Chow was Co-founder, President and CEO of Vitaeris (acquired by CSL Behring) and held senior positions in business development at Alder Biopharmaceuticals, Gilead Sciences, Corus Pharma (acquired by Gilead Sciences) and Diversa Corporation. Chow has over two decades of experience leading business development and corporate strategy in both large and small biopharmaceutical companies. ![]() ![]() Adding their expertise in international regulatory affairs, global operations, business development and corporate strategy will be an invaluable toolset for ALSP’s portfolio of companies. Yeager will join a top-tier group of Operating Partners to assist with the evaluation of new business opportunities, support current (and future) ALSP portfolio companies and serve in a variety of operating and advisory roles.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |